West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support its customers by delivering over 40 billion components and devices each year.
Company profile
Ticker
WST
Exchange
Website
CEO
Eric Green
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • 3M • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
Former names
WEST CO INC
SEC CIK
Corporate docs
Subsidiaries
West Pharmaceutical • Tech Group Europe Limited • Tech Group • TGPR Holdings Limited • WD SG Pte. Ltd. • West Services and Solutions, LLC • West Contract Manufacturing, LLC • West Pharma. Services IL, Ltd. • West Pharmaceutical Products Ireland, Ltd. • West Pharmaceutical Services Australia ...
IRS number
231210010
WST stock data
Analyst ratings and price targets
Latest filings (excl ownership)
ARS
2022 FY
Annual report to shareholders
15 Mar 23
DEFA14A
Additional proxy soliciting materials
15 Mar 23
DEF 14A
Definitive proxy
15 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
West Announces Fourth-Quarter and Full-Year 2022 Results
16 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
8-K
West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend
27 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
8-K
West Announces Second-Quarter 2022 Results
28 Jul 22
8-K
West Elects New Director to the Board
27 Jul 22
Transcripts
WST
Earnings call transcript
2022 Q4
16 Feb 23
WST
Earnings call transcript
2022 Q3
27 Oct 22
WST
Earnings call transcript
2022 Q2
28 Jul 22
WST
Earnings call transcript
2022 Q1
28 Apr 22
WST
Earnings call transcript
2021 Q4
17 Feb 22
WST
Earnings call transcript
2021 Q3
28 Oct 21
WST
Earnings call transcript
2021 Q2
29 Jul 21
WST
Earnings call transcript
2021 Q1
30 Apr 21
WST
Earnings call transcript
2020 Q4
18 Feb 21
WST
Earnings call transcript
2020 Q3
22 Oct 20
Latest ownership filings
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q4 2022
92.9% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 616 |
| Opened positions | 91 |
| Closed positions | 89 |
| Increased positions | 223 |
| Reduced positions | 222 |
| 13F shares | Current |
|---|---|
| Total value | 16.00 tn |
| Total shares | 69.02 mm |
| Total puts | 94.00 k |
| Total calls | 72.70 k |
| Total put/call ratio | 1.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 8.99 mm | $2.12 tn |
| BLK Blackrock | 8.15 mm | $1.92 tn |
| BK Bank Of New York Mellon | 3.60 mm | $847.54 bn |
| STT State Street | 3.36 mm | $790.66 bn |
| APG Asset Management | 2.56 mm | $601.01 bn |
| BEN Franklin Resources | 2.47 mm | $581.48 bn |
| T. Rowe Price | 2.30 mm | $540.06 bn |
| FMR | 1.79 mm | $421.10 bn |
| T. Rowe Price Investment Management | 1.72 mm | $403.66 bn |
| Geode Capital Management | 1.51 mm | $353.64 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Mar 23 | Silji Abraham | Common Stock | Sell | Dispose S | No | No | 322.5667 | 1,500 | 483.85 k | 4,209.3 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 324.29 | 1,131 | 366.77 k | 128,574.087 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 323.3804 | 5,277 | 1.71 mm | 123,297.087 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 322.4874 | 26,753 | 8.63 mm | 96,544.087 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 321.6138 | 7,685 | 2.47 mm | 88,859.087 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 320.6002 | 3,154 | 1.01 mm | 85,705.087 |
| 7 Mar 23 | Green Eric Mark | Common Stock | Option exercise | Acquire M | No | Yes | 57.38 | 50,000 | 2.87 mm | 135,705.087 |
| 7 Mar 23 | Green Eric Mark | Stock Option Common Stock | Option exercise | Dispose M | No | No | 57.38 | 50,000 | 2.87 mm | 198,132 |
| 1 Mar 23 | Birkett Bernard | Common Stock | Grant | Dispose A | No | No | 318.28 | 43 | 13.69 k | 4,366 |
| 1 Mar 23 | Silji Abraham | Common Stock | Grant | Acquire A | No | No | 318.28 | 234 | 74.48 k | 5,709.3 |
News
A Bullish Sign Appears On West Pharmaceutical Servs's Chart
13 Mar 23
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $375
17 Feb 23
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
16 Feb 23
Analyst Views West Pharmaceutical's Q4 Earnings Impressive Despite Headwinds
16 Feb 23
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
16 Feb 23
Press releases
West Announces Second-Quarter 2023 Dividend
3 Mar 23
West Announces Fourth-Quarter and Full-Year 2022 Results
16 Feb 23
West Expands Corning Collaboration and Launches First Product
8 Feb 23
West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
2 Feb 23
West Announces Three New Product Innovations at Pharmapack Europe
31 Jan 23